1,972
Views
14
CrossRef citations to date
0
Altmetric
Surgery

Similar patient outcomes yet different hospital costs between flowable hemostatic agents

, , , &
Pages 735-745 | Accepted 13 Apr 2015, Published online: 01 Jun 2015

References

  • Moss, R. Management of Surgical Hemostasis: An Independent Study Guide. AORN, Inc, Denver, CO; 2013
  • Lewis KM, Atlee HD, Mannone AJ, et al. Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model. J Invest Surg 2013;26:141-8
  • Sileshi B, Achneck HE, Lawson JH. Management of surgical hemostasis: topical agents. Vascular 2008;16(Suppl 1):S22-8
  • Emilia M, Luca S, Francesca B, et al. Topical hemostatic agents in surgical practice. Transfus Apher Sci 2011;45:305-11
  • Gazzeri R, Galarza M, Alfier A. Safety biocompatibility of gelatin hemostatic matrix (Floseal and Surgiflo) in neurosurgical procedures. Surg Technol Int 2012;22:49-54
  • Saif R, Jacob M, Robinson S, et al. Use of fibrin-based sealants and gelatin-matrix hemostats in laparoscopic liver surgery. Surg Laparosc Endosc Percutan Tech 2011;21:131-41
  • Spotnitz WD, Burks S. Hemostats, sealants, and adhesives: components of the surgical toolbox. Transfusion 2008;48:1502-16
  • Block JE. Severe blood loss during spinal reconstructive procedures: the potential usefulness of topical hemostatic agents. Med Hypotheses 2005;65:617-21
  • Oz MC, Cosgrove DM III, Badduke BR, et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group. Ann Thorac Surg 2000;69:1376-82
  • Klemcke HG. Evaluation of FloSeal as a potential intracavitary hemostatic agent. J Trauma 2006;60:385-9
  • Reuthebuch O, Lachat ML, Vogt P, et al. FloSeal: a new hemostyptic agent in peripheral vascular surgery. Vasa 2000;29:204-6
  • Nogueira L, Katz D, Pinochet R, et al. Comparison of gelatine matrix-thrombin sealants used during laparoscopic partial nephrectomy. BJU Int 2008;102:1670-4
  • Pace G, Saldutto P, Vicentini C, et al. Haemostatics in surgery and our experience in the enucleoresection of renal cell carcinoma. World J Surg Oncol 2010;8:37
  • Bak JB, Singh A, Shekarriz B. Use of gelatin matrix thrombin tissue sealant as an effective hemostatic agent during laparoscopic partial nephrectomy. J Urol 2004;171:780-2
  • Fiss I, Danne M, Stendel R. Use of gelatin-thrombin matrix hemostatic sealant in cranial neurosurgery. Neurol Med Chir (Tokyo) 2007;47:462-7
  • Gazzeri R, Galarza M, Neroni M, et al. Minimal craniotomy and matrix hemostatic sealant for the treatment of spontaneous supratentorial intracerebral hemorrhage. J Neurosurg 2009;110:939-42
  • Woodworth BA, Chandra RK, LeBenger JD, et al. A gelatin-thrombin matrix for hemostasis after endoscopic sinus surgery. Am J Otolaryngol 2009;30:49-53
  • Izzo F, Di Giacomo R, Falco P, et al. Efficacy of a haemostatic matrix for the management of bleeding in patients undergoing liver resection: results from 237 cases. Curr Med Res Opin 2008;24:1011-15
  • Helito CP, Gobbi RG, Castrillon LM, et al. Comparison of Floseal(r) and electrocautery in hemostasis after total knee arthroplasty. Acta Ortop Bras 2013;21:320-2
  • Kim HJ, Fraser MR, Kahn B, et al. The efficacy of a thrombin-based hemostatic agent in unilateral total knee arthroplasty: a randomized controlled trial. J Bone Joint Surg Am 2012;94:1160-5
  • Gazzeri R, Galarza M, Neroni M, et al. Hemostatic matrix sealant in neurosurgery: a clinical and imaging study. Acta Neurochir (Wien) 2011;153:148-54; discussion 155
  • Floseal Hemostatic Matrix Instructions for Use. Hayward, CA: Baxter Healthcare Corporation
  • Elgafy H, Bransford RJ, McGuire RA, et al. Blood loss in major spine surgery: are there effective measures to decrease massive hemorrhage in major spine fusion surgery? Spine (Phila Pa 1976) 2010;35:S47-56
  • Rajaee SS, Bae HW, Kanim LE, et al. Spinal fusion in the United States: analysis of trends from 1998 to 2008. Spine (Phila Pa 1976) 2012;37:67-76
  • Steiner C, Andrews R, Barrett M, et al. HCUP Projections: Mobility/Orthopedic Procedures 2011 to 2012. HCUP Projections Report # 2012-03. Available from: http://www.hcup-us.ahrq.gov/reports/projections/2012-03.pdf [last accessed 13 Nov 2014].
  • 3Mtm APR DRG Classification System, 3M Health Information Systems, Wallingford, CT. GRP-041 Version 26.1. 10/2008
  • Yao HH, Hong MK, Drummond KJ. Haemostasis in neurosurgery: what is the evidence for gelatin-thrombin matrix sealant? J Clin Neurosci 2013;20:349-56
  • Renkens KL, Jr., Payner TD, Leipzig TJ, et al. A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine (Phila Pa 1976) 2001;26:1645-50
  • Ereth MH, Schaff M, Ericson EF, et al. Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model. Neurosurgery 2008;63:369-72; discussion 372
  • Schreiber MA, Neveleff DJ. Achieving hemostasis with topical hemostats: making clinically and economically appropriate decisions in the surgical and trauma settings. AORN J 2011;94:S1-20
  • Boucher BA, Hannon TJ. Blood management: a primer for clinicians. Pharmacotherapy 2007;27:1394-411
  • Blanchette CM, Wang PF, Joshi AV, et al. Cost and utilization of blood transfusion associated with spinal surgeries in the United States. Eur Spine J 2007;16:353-63

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.